MedTrace Logo

Omega-3 Supplementation and Behavior Problems

NCT02334098 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 324

Last updated 2018-07-18

No results posted yet for this study

Summary

The objectives of this project are as follows:

1. To assess whether omega-3 dietary supplementation for six months can reduce externalizing behavior problems (antisocial and aggressive behavior) in schoolchildren aged 8 to 18, both at the end of treatment and six months post-treatment
2. To assess whether omega-3 supplementation is more effective in children with more psychopathic-like traits.

Conditions

  • Aggression
  • Antisocial Behavior
  • Antisocial Personality

Interventions

DIETARY_SUPPLEMENT

Omega-3 supplemented drink

The drink has apple/ pear/ pomegranate taste which is well accepted by children and adolescents, is rich in natural antioxidants to help prevent oxidation of omega-3. The drink can be taken at any time during the day. 1/3 of the participants will be assigned to the omega-3 group after randomization. They are going to take the treatment for 6 months. They will be assessed at baseline, end of treatment and 6 months post-treatment.

DIETARY_SUPPLEMENT

Smartfish

Treatment duration is 6 months. They will be assessed at baseline (0 months), end of treatment (6 months) and 6 months post-treatment (12 months).

Sponsors & Collaborators

  • University of Pennsylvania

    collaborator OTHER

  • The University of Hong Kong

    collaborator OTHER

  • Brooklyn College of the City University of New York

    collaborator OTHER

  • Dr. Annis Fung

    lead OTHER

Principal Investigators

  • Annis Fung, Ph.D. · City University of Hong Kong

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2017-07-31
Completion
2018-07-31

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02334098 on ClinicalTrials.gov